Clinical TrialsSearch results
Number of results: 221
Other
- Phase II trial of cetuximab plus irinotecan for FOLFOX and FOLFIRI-refractory patients with EGFR-positive advanced and/or metastatic colorectal cancer, evaluation of the safety and efficacy based on KRAS mutation status (T-CORE0801)
- 3rd line or later therapy for unresectable advanced and/or recurrent colorectal cancer
- NPO T-CORE (Tohoku Clinical Oncology Research and Education Society)
- 2009-01-31
Other
- Phase II Study of Thymomectomy for Thymoma Localized in the Thymus
- thymoma
- Japanese Association for Research on the Thymus
- 2007-04-01
Other
- Phase II study of SMILE chemotherapy for stage IV or relapsed/refractory extranodal NK/T-cell lymphoma
- extranodal NK/T-cell lymphoma, nasal type
- NK-cell Tumor Study Group
- 2007-05-14
Other
- Phase II study of neoadjuvant treatment with Exemestane for 24 weeks in postmenopausal women with hormone receptor positive Stage II or IIIA breast cancer.
- Breast Cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2006-03-06
Other
- Phase II study of Neoadjuvant chemotherapy with Gemcitabine and S1 (GS therapy) for resectable pancreatic carcinoma
- resectable pancreatic cancer
- Department of surgery, Tohoku University
- 2008-11-13
Other
- Phase II study of micafungin as empirical antifungal therapy for febrile neutropenic patients (C-SHOT 0503 study)
- Febrile neutropenia
- Center for Supporting Hematology-Oncology Trials (C-SHOT)
- 2006-03-30
Other
- Phase II study of irinotecan and tegafur gimeracil for NSCLC with EGFR mutation which resistant to EGFR-TKI
- Non-small-cell lung cancer
- North Japan Lung Cancer Study Group
- 2010-08-31
Other
- Phase II study of imatinib mesylate for treatment of Philadelphia Chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in children: A Japanese Cooperative Trial
- Philadelphia Chromosome-positive acute lymphoblastic leukemia
- Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)
- 2005-12-01
Other
- Phase II study of gefitinib in untreated advanced non-small cell lung cancer with EGF receptor mutations
- non-small cell lung cancer
- Hokkaido Lung Cancer Clinical Study Group
- 2005-09-12
Other
- Phase II study of FOLFIRI plus Bevacitumab in the treatment of Japanese patients with advanced colorectal cancer.
- Colorectal cancer
- Japan Clinical Cancer Research Organization
- 2008-10-20